SMC, a solutions provider in the manufacturing of pharmaceutical and medical devices, announced the opening of Cambridge Pharma—a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000-sq ft facility located at the Cambridge Research Park, UK, includes a purpose-built sterile fill-finish facility, a process development laboratory and an analytical laboratory. Services include process development and scale up, sterile fill-finish for clinical trials, QC and stability testing and QP release of clinical trials supplies.

The sterile-fill finish facility is designed to meet up-to-date regulatory requirements and includes state-of-the-art dynamic and independent HVAC systems and two clean rooms. Each clean room is equipped with isolators and fill-finish equipment to support batch sizes from 100 units to 15,000 units in vials, cartridges, or syringes. Cambridge Pharma’s industrialisation engineers can take a customer’s laboratory scale formulation and develop a process for clinical trials in phases one to three including process development and filling of viscous formulations, suspensions, and gels. Non-standard primary drug containers can be accommodated, and container closure integrity tests and associated equipment can also be developed.